JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nepomuceno, C. G.
Right arrow Articles by Little, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nepomuceno, C. G.
Right arrow Articles by Little, J. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 146, Issue 3, 294-297, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


IN VITRO EFFECTS OF THYROXINE AND ANALOGUES ON THE RENAL UPTAKE OF PAH AND TEA

Carmelo G. Nepomuceno 1 and J. Maxwell Little 1

1 Department of Pharmacology, The Bowman Gray School of Medicine of Wake Forest College, Winston-Salem, North Carolina

The in vitro addition of l-thyroxine (7.4 x 10-9 M), tetraiodothyropropionic acid (7.4 x 10-9 M), tetraiodothyroacetic acid (7.4 x 10-7 M), l-triiodothyronine (7.4 x 10-6 M), triiodothyropropionic acid (7.4 x 10-6 M), and triiodothyroacetic acid (7.4 x 10-5 M) significantly depressed (P .001) PAR uptake by rat kidney cortex slices. l-Thyronine (7.4 x 10-5 M) was inactive. The presence of the iodine substituents is essential for inhibitory action. The tetraiodothyronines were more potent inhibitors of PAH uptake than their corresponding triiodo analogues. Modification of the alanine side chain resulted in increased inhibitory potency. Only triiodothyropropionic acid (7.4 x 10-5 M; P .01) and triiodothyroacetic acid (7.4 x 10-5 M; P .001) had an inhibitory effect on TEA transport. It is suggested that thyroxine and its analogues depress PAH uptake by competing for the same transport system.

Accepted on September 9, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.